Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperpolarized Xenon-129 MRI in E-cigarette Users
NCT04662658Phase 2Recruiting
- Sponsor
- University of Virginia
- Start
- Nov 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of hyperpolarized xenon gas in not applicable; "lung injury" is not a specific disease, sponsored by University of Virginia. Primary endpoint: Hyperpolarized xenon-129 MRI of the lung at 12 months. Started Nov 2020; status: recruiting.
02
Drugs
hyperpolarized xenon gas
03
Conditions
not applicable; "lung injury" is not a specific disease
Beyond the preview
Go deeper on NCT04662658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04662658.